Truist Financial
MEDP icon

Truist Financial’s Medpace MEDP Stock Holding History

Truist Financial’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.28M Buy
13,742
+598
+5% +$276K 0.01% 753
2026
Q1 		$6.31M Buy
13,144
+1,327
+11% +$679K 0.01% 763
2025
Q4 		$6.64M Sell
11,817
-2,708
-19% -$1.54M 0.01% 745
2025
Q3 		$7.47M Buy
14,525
+1,627
+13% +$710K 0.01% 721
2025
Q2 		$4.05M Buy
12,898
+1,197
+10% +$359K 0.01% 958
2025
Q1 		$3.57M Buy
11,701
+1,424
+14% +$479K 0.01% 964
2024
Q4 		$3.41M Buy
10,277
+6,417
+166% +$2.18M 0.01% 994
2024
Q3 		$1.29M Buy
3,860
+160
+4% +$60.8K ﹤0.01% 1411
2024
Q2 		$1.52M Buy
3,700
+648
+21% +$257K ﹤0.01% 1402
2024
Q1 		$1.23M Sell
3,052
-636
-17% -$224K ﹤0.01% 1512
2023
Q4 		$1.13M Buy
3,688
+1,035
+39% +$279K ﹤0.01% 1536
2023
Q3 		$642K Buy
2,653
+231
+10% +$59.1K ﹤0.01% 1781
2023
Q2 		$582K Buy
2,422
+766
+46% +$159K ﹤0.01% 1879
2023
Q1 		$311K Buy
1,656
+581
+54% +$120K ﹤0.01% 2245
2022
Q4 		$228K Sell
1,075
-259
-19% -$51.7K ﹤0.01% 2365
2022
Q3 		$210K Buy
+1,334
New +$213K ﹤0.01% 2282
2022
Q1 		– Sell
-3,572
Closed -$777K – 2773
2021
Q4 		$777K Sell
3,572
-1,798
-33% -$377K ﹤0.01% 1778
2021
Q3 		$1.02M Sell
5,370
-105
-2% -$19.2K ﹤0.01% 1593
2021
Q2 		$967K Sell
5,475
-243
-4% -$41.9K ﹤0.01% 1671
2021
Q1 		$938K Sell
5,718
-3,628
-39% -$555K ﹤0.01% 1631
2020
Q4 		$1.3M Buy
9,346
+2,371
+34% +$299K ﹤0.01% 1355
2020
Q3 		$780K Sell
6,975
-69
-1% -$7.98K ﹤0.01% 1480
2020
Q2 		$655K Buy
7,044
+331
+5% +$28.2K ﹤0.01% 1483
2020
Q1 		$492K Sell
6,713
-6,595
-50% -$573K ﹤0.01% 1566
2019
Q4 		$1.12M Buy
+13,308
New +$1.03M ﹤0.01% 1385

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Truist Financial's MEDP Position: Q2 2026 in Review

Truist Financial increased its Medpace (MEDP) stake by 4.5% in Q2 2026, buying an estimated $276K and bringing the position to 13,742 shares worth $7.28M. The position accounts for 0.01% of the portfolio, ranked #753.

Truist Financial first reported a position in MEDP in Q4 2019 and has held it in 25 quarters since. The position peaked at $7.47M in Q3 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Truist Financial held 13,742 shares of Medpace worth $7.28M as of Q2 2026.
  • Truist Financial bought 598 Medpace shares in Q2 2026, an estimated $276K.
  • Medpace made up 0.01% of Truist Financial's portfolio in Q2 2026, its #753 holding.
  • Truist Financial first reported a position in Medpace in Q4 2019 and has held it in 25 quarters since.
  • Truist Financial's Medpace position peaked at $7.47M in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.